Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Otolaryngol Head Neck Surg. 2012 Oct;20(5):416-9. doi: 10.1097/MOO.0b013e328357a6c8.

Endolymphatic hydrops perspectives 2012.

Author information

  • 1Department of Otolaryngology, University of Florida, Gainesville, Florida, USA.

Abstract

PURPOSE OF REVIEW:

Endolymphatic hydrops remains a significant cause of morbidity secondary to vertigo, hearing loss, and tinnitus. The purpose of this report is to summarize the most clinically relevant publications on endolymphatic hydrops over the past 2 years.

RECENT FINDINGS:

Hydrops has historically been a diagnosis of exclusion, but recent efforts has shown a role for MRI with intratympanic gadolinium. Cochrane reviews of intratympanic dexamethasone and gentamicin found inadequate level 1 evidence to support their use.

SUMMARY:

High-level evidence to guide therapy is lacking. MRI holds potential for definitive diagnosis.

PMID:
22902416
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk